NasdaqCM - Delayed Quote • USD
Regencell Bioscience Holdings Limited (RGC)
At close: April 25 at 4:00 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Yat-Gai Au | Founder, Chairman & CEO | -- | -- | 1973 |
Ms. Michelle Chan | Financial Controller | -- | -- | -- |
Mr. Wai Hong Chung | COO & Chief Strategy Officer | 245.64k | -- | 1977 |
Dr. Yi-Chung Chao Ph.D. | Special Advisor & Director | 249.74k | -- | 1964 |
Mr. Tien Hsiang Chau | Executive Officer | 123.61k | -- | 1970 |
Ms. Antonia Assang | Senior Vice President of Project Management | -- | -- | -- |
Mr. Yat-Pui Au | Chief Business Officer | -- | -- | 1974 |
Regencell Bioscience Holdings Limited
Chinachem Leighton Plaza
9th Floor 29 Leighton Road
Causeway Bay
Hong Kong
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 12
Description
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder, as well as infectious diseases. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Corporate Governance
Regencell Bioscience Holdings Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- Jan 02, 20246-K: Corporate Changes & Voting MattersSee Full Filing
- Dec 15, 20236-K: Corporate Changes & Voting MattersSee Full Filing
- Oct 27, 202320-F: Periodic Financial ReportsSee Full Filing
- Jun 15, 20236-K: Corporate Changes & Voting MattersSee Full Filing
- Jun 05, 20236-K: Corporate Changes & Voting MattersSee Full Filing
Upcoming Events
Upcoming Events Information Not Available
Related Tickers
YCBD cbdMD, Inc.
0.8711
-3.21%
OPTN OptiNose, Inc.
0.8604
-4.93%
UPC Universe Pharmaceuticals INC
2.1800
-5.22%
CLVR Clever Leaves Holdings Inc.
4.1100
+0.98%
CPHI China Pharma Holdings, Inc.
0.3023
-7.27%
LFCR Lifecore Biomedical, Inc.
6.60
-0.68%
DUTV Digital Utilities Ventures, Inc.
0.0089
-5.32%
IGPK Integrated Cannabis Solutions, Inc.
0.0127
-18.59%
SXTC China SXT Pharmaceuticals, Inc.
1.0500
+1.94%
PAHC Phibro Animal Health Corporation
12.73
+2.33%